RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. UniSuper
U

UniSuper portfolio

UniSuper has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $100M.
Latest deal: Aravax · Jan 23, 2024.
About this page

Its most recent investment on record is Aravax's $42M Series B+ round in January 2024, alongside Novartis Venture Fund, Agati Capital, Breakthrough Victoria and 1 other. By category, its portfolio leans toward Health and bio (1) and Commerce and retail (1). It has co-invested with Uniseed, Novartis Venture Fund and Agati Capital, most often Uniseed (2 rounds).

What UniSuper invests in

How UniSuper invests

StageDealsCapital in rounds
Series B+ 2 100%$100M
YearDealsCapital in rounds
2022 1 50%$58M
2024 1 50%$42M

UniSuper portfolio companies

CompanyRound with UniSuperTotal raisedLatest raise
AAravax
Health and bio
Series B+ · $42M$62MJan 23, 2024
Series B+
MMorse Micro
AI infrastructure and compute
Series B+ · $58M$115.41MNov 28, 2022
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name UniSuper. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists UniSuper, which is a subset of its real portfolio. API: /api/v1/investors/unisuper (get a free API key). More: the most active VC firms and new venture capital funds.